{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:24:39Z","timestamp":1772565879482,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.molimm.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T19:36:01Z","timestamp":1521488161000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["In silico design of Mycobacterium tuberculosis epitope ensemble vaccines"],"prefix":"10.1016","volume":"97","author":[{"given":"Preksha","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaymisha","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro A.","family":"Reche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Gatherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8542-7067","authenticated-orcid":false,"given":"Darren R.","family":"Flower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.molimm.2018.03.007_bib0005","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12033-013-9696-y","article-title":"A comparative approach to strategies for cloning, expression, and purification of Mycobacterium tuberculosis mycolyl transferase 85\u2009B and evaluation of immune responses in BALB\/c mice","volume":"56","author":"Aghababa","year":"2014","journal-title":"Mol. Biotechnol."},{"issue":"17","key":"10.1016\/j.molimm.2018.03.007_bib0010","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molimm.2018.03.007_bib0015","doi-asserted-by":"crossref","first-page":"284170","DOI":"10.1155\/2014\/284170","article-title":"Mycobacterium tuberculosis H37Rv: in silico drug targets identification by metabolic pathways analysis","volume":"2014","author":"Amir","year":"2014","journal-title":"Int. J. Evol. Biol."},{"issue":"1","key":"10.1016\/j.molimm.2018.03.007_bib0020","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1128\/IAI.01290-06","article-title":"The combined CTA1-DD\/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis","volume":"75","author":"Andersen","year":"2007","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.molimm.2018.03.007_bib0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2217\/imt.15.60","article-title":"Strategies to improve BCG vaccine efficacy","volume":"7","author":"Bali","year":"2015","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.molimm.2018.03.007_bib0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1110\/ps.041059505","article-title":"Benchmarking B cell epitope prediction: underperformance of existing methods","volume":"14","author":"Blythe","year":"2005","journal-title":"Protein Sci."},{"issue":"6685","key":"10.1016\/j.molimm.2018.03.007_bib0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2018.03.007_bib0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jmgm.2017.10.004","article-title":"Insilico design of knowledge-based Plasmodium falciparum epitope ensemble vaccines","volume":"78","author":"Damfo","year":"2017","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.molimm.2018.03.007_bib0045","doi-asserted-by":"crossref","first-page":"208371","DOI":"10.1155\/2010\/208371","article-title":"Assessment of the genetic diversity of Mycobacterium tuberculosis esxA, esxH, and fbpB genes among clinical isolates and its implication for the future immunization by new tuberculosis subunit vaccines Ag85B-ESAT-6 and Ag85B-TB10.4","volume":"2010","author":"Davila","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.molimm.2018.03.007_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1475-2859-5-23","article-title":"Live bacterial vaccines--a review and identification of potential hazards","volume":"5","author":"Detmer","year":"2006","journal-title":"Microb. Cell Fact."},{"issue":"4","key":"10.1016\/j.molimm.2018.03.007_bib0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1399-0039.1997.tb02768.x","article-title":"HLA-DR 52- and 51-associated DRB1 alleles in Kenya, east africa","volume":"49","author":"Dunand","year":"1997","journal-title":"Tissue Antigens."},{"issue":"3","key":"10.1016\/j.molimm.2018.03.007_bib0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.rmedc.2010.12.003","article-title":"Disseminated BCG disease: a case report","volume":"4","author":"Eccles","year":"2011","journal-title":"Respir. Med. CME"},{"issue":"26","key":"10.1016\/j.molimm.2018.03.007_bib0065","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.vaccine.2016.02.079","article-title":"Status of vaccine research and development of vaccines for tuberculosis","volume":"34","author":"Evans","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.molimm.2018.03.007_bib0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijid.2005.06.002","article-title":"Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates","volume":"10","author":"Franco-Paredes","year":"2006","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.molimm.2018.03.007_bib0075","doi-asserted-by":"crossref","first-page":"W35","DOI":"10.1093\/nar\/gkn211","article-title":"PVS: a web server for protein sequence variability analysis tuned to facilitate conserved epitope discovery","volume":"36","author":"Garcia-Boronat","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molimm.2018.03.007_bib0080","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tube.2016.07.005","article-title":"Safety and immunogenicity of the M72\/AS01E candidate tuberculosis vaccine in adults with tuberculosis: a phase II randomised study","volume":"100","author":"Gillard","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"10.1016\/j.molimm.2018.03.007_bib0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","article-title":"Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes","volume":"63","author":"Greenbaum","year":"2011","journal-title":"Immunogenetics"},{"key":"10.1016\/j.molimm.2018.03.007_bib0090","series-title":"Tuberculosis in Adults and Children","author":"Heemskerk","year":"2015"},{"key":"10.1016\/j.molimm.2018.03.007_bib0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ebiom.2016.04.010","article-title":"Safety and immunogenicity of the recombinant BCG vaccine AERAS-422 in healthy BCG-naive adults: a randomized, active-controlled, first-in-human phase 1 trial","volume":"7","author":"Hoft","year":"2016","journal-title":"EBioMedicine"},{"issue":"45","key":"10.1016\/j.molimm.2018.03.007_bib0100","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1016\/j.vaccine.2014.09.001","article-title":"The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses","volume":"32","author":"Kagina","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2018.03.007_bib0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coi.2014.01.009","article-title":"Challenges and responses in human vaccine development","volume":"28","author":"Kaufmann","year":"2014","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2018.03.007_bib0110","doi-asserted-by":"crossref","first-page":"e10751","DOI":"10.1371\/journal.pone.0010751","article-title":"High-throughput high-resolution class I HLA genotyping in east africa","volume":"5","author":"Koehler","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.molimm.2018.03.007_bib0115","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines (Basel)."},{"issue":"4","key":"10.1016\/j.molimm.2018.03.007_bib0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/sji.12465","article-title":"Global efforts in the development of vaccines for tuberculosis: requirements for improved vaccines against mycobacterium tuberculosis","volume":"84","author":"Mendez-Samperio","year":"2016","journal-title":"Scand. J. Immunol."},{"issue":"9","key":"10.1016\/j.molimm.2018.03.007_bib0125","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2217\/imt-2016-0005","article-title":"Research progress in the field of immunotherapeutic vaccination in human TB and the way ahead","volume":"8","author":"Mendez-Samperio","year":"2016","journal-title":"Immunotherapy"},{"issue":"9","key":"10.1016\/j.molimm.2018.03.007_bib0130","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1365-3156.2010.02581.x","article-title":"Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa","volume":"15","author":"Migliori","year":"2010","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.molimm.2018.03.007_bib0135","doi-asserted-by":"crossref","first-page":"601943","DOI":"10.1155\/2013\/601943","article-title":"Selection of conserved epitopes from hepatitis C virus for pan-populational stimulation of T-cell responses","volume":"2013","author":"Molero-Abraham","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"3","key":"10.1016\/j.molimm.2018.03.007_bib0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S2213-2600(15)00037-5","article-title":"Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial","volume":"3","author":"Ndiaye","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"10.1016\/j.molimm.2018.03.007_bib0145","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/eji.201243245","article-title":"Mycobacterium tuberculosis PstS1 amplifies IFN-gamma and induces IL-17\/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation","volume":"43","author":"Palma","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.molimm.2018.03.007_bib0150","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/bioinformatics\/btm076","article-title":"COBALT: constraint-based alignment tool for multiple protein sequences","volume":"23","author":"Papadopoulos","year":"2007","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.molimm.2018.03.007_bib0155","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1371\/journal.pbio.0030091","article-title":"The immune epitope database and analysis resource: from vision to blueprint","volume":"3","author":"Peters","year":"2005","journal-title":"PLoS Biol."},{"issue":"5","key":"10.1016\/j.molimm.2018.03.007_bib0160","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00251-005-0803-5","article-title":"The design and implementation of the immune epitope database and analysis resource","volume":"57","author":"Peters","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/j.molimm.2018.03.007_bib0165","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1472-6807-7-64","article-title":"Antibody-protein interactions: benchmark datasets and prediction tools evaluation","volume":"7","author":"Ponomarenko","year":"2007","journal-title":"BMC Struct. Biol."},{"issue":"11","key":"10.1016\/j.molimm.2018.03.007_bib0170","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cub.2005.04.050","article-title":"Pathogen-driven selection and worldwide HLA class I diversity","volume":"15","author":"Prugnolle","year":"2005","journal-title":"Curr. Biol."},{"issue":"10","key":"10.1016\/j.molimm.2018.03.007_bib0175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.6026\/97320630004447","article-title":"Discriminating antigen and non-antigen using proteome dissimilarity: bacterial antigens","volume":"4","author":"Ramakrishnan","year":"2010","journal-title":"Bioinformation"},{"issue":"5 (1)","key":"10.1016\/j.molimm.2018.03.007_bib0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.6026\/97320630005035","article-title":"Discriminating antigen and non-antigen using proteome dissimilarity II: viral and fungal antigens","volume":"24","author":"Ramakrishnan","year":"2010","journal-title":"Bioinformation"},{"issue":"1","key":"10.1016\/j.molimm.2018.03.007_bib0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.6026\/97320630005039","article-title":"Discriminating antigen and non-antigen using proteome dissimilarity III: tumour and parasite antigens","volume":"5","author":"Ramakrishnan","year":"2010","journal-title":"Bioinformation"},{"issue":"2","key":"10.1016\/j.molimm.2018.03.007_bib0190","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.4081\/idr.2016.6570","article-title":"Tuberculosis 2015: burden, challenges and strategy for control and elimination","volume":"8","author":"Raviglione","year":"2016","journal-title":"Infect. Dis. Rep."},{"issue":"12","key":"10.1016\/j.molimm.2018.03.007_bib0195","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1517\/14712598.2012.721768","article-title":"An update on vaccines for tuberculosis \u2013 there is more to it than just waning of BCG efficacy with time","volume":"12","author":"Romano","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"issue":"21","key":"10.1016\/j.molimm.2018.03.007_bib0200","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1093\/bioinformatics\/btw399","article-title":"Towards the knowledge-based design of universal influenza epitope ensemble vaccines","volume":"32","author":"Sheikh","year":"2016","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.molimm.2018.03.007_bib0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PPO.0b013e318233e5b2","article-title":"The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?","volume":"17","author":"Slingluff","year":"2011","journal-title":"Cancer J."},{"issue":"8","key":"10.1016\/j.molimm.2018.03.007_bib0210","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1586\/14760584.2014.929947","article-title":"Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future?","volume":"13","author":"Smaill","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.molimm.2018.03.007_bib0215","unstructured":"WHO, 2017. Tuberculosis fact sheet, [online]. http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/ (Accessed: 15.03.17)."},{"issue":"22","key":"10.1016\/j.molimm.2018.03.007_bib0220","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.molimm.2018.03.007_bib0225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/thoraxjnl-2014-205202","article-title":"TB vaccine development: where are we and why is it so difficult?","volume":"70","author":"Wilkie","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.molimm.2018.03.007_bib0230","first-page":"1","article-title":"Successes and failures in human tuberculosis vaccine development","author":"Zenteno-Cuevas","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.molimm.2018.03.007_bib0235","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-8794-1-18","article-title":"Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses","volume":"1","author":"Zvi","year":"2008","journal-title":"BMC Med. Genomics"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018300580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018300580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:35:19Z","timestamp":1534984519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589018300580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":47,"alternative-id":["S0161589018300580"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2018.03.007","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico design of Mycobacterium tuberculosis epitope ensemble vaccines","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}